Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Investigating the role of dendritic cells in the development of Systemic Autoimmune Rheumatic Diseases.

FY 2020-21

Summary
Systemic autoimmune rheumatic diseases (SARDs), including Systemic Lupus Erythematosus (SLE) and Sjogren's disease (SjD), are chronic conditions characterized by recurring flares of disease activity and a variety of clinical symptoms. Often, when people first develop symptoms of SARD, there is already irreversible organ damage. The bloodwork changes (anti-nuclear antibodies; ANA) associated with these conditions can be found many years before the development of symptoms. While this would suggest that these changes could be used to predict development of disease, they are also frequently found in healthy women (~20%), of whom >90% will never develop SARD. There is still much to be understood regarding the cause of SARDs and the immune changes that are associated with the development of these diseases. To study the immune changes that lead to the development of SARD, our laboratory is following a large number of individuals who have some of the bloodwork changes of SARD but who have no clinical symptoms. Some of these individuals have developed disease and our preliminary data suggests that these progressors have altered function of a subset of immune cells, known as dendritic cells (DCs). These cells have previously been shown to play an important role in the activation of the immune subsets that lead to ANAs. By using advanced research techniques, we will further characterize the functional differences between DCs from SARD patients and ANA+ individuals who have no symptoms. Additionally, we will elucidate the immune changes that distinguish the ANA+ individuals who progress, from those who do not. Ultimately, this study will define the immune mechanisms that result in the development of SARD and potentially lead to novel treatments that can be used to prevent disease.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
449702
Name
Nassar Carol
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of dendritic cells in the development of Systemic Autoimmune Rheumatic Diseases.
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anti-Nuclear Antibodies; Autoimmunity; Bioinformatics; Cytokine Profiling; Dendritic Cells; Elisas; Flow Cytometry; Rna-Sequencing; Sjogren'S Disease; Systemic Lupus Erythematosus
Abstract
Systemic autoimmune rheumatic diseases (SARDs), including Systemic Lupus Erythematosus (SLE) and Sjogren's disease (SjD), are chronic conditions characterized by recurring flares of disease activity and a variety of clinical symptoms. Often, when people first develop symptoms of SARD, there is already irreversible organ damage. The bloodwork changes (anti-nuclear antibodies; ANA) associated with these conditions can be found many years before the development of symptoms. While this would suggest that these changes could be used to predict development of disease, they are also frequently found in healthy women (~20%), of whom >90% will never develop SARD. There is still much to be understood regarding the cause of SARDs and the immune changes that are associated with the development of these diseases. To study the immune changes that lead to the development of SARD, our laboratory is following a large number of individuals who have some of the bloodwork changes of SARD but who have no clinical symptoms. Some of these individuals have developed disease and our preliminary data suggests that these progressors have altered function of a subset of immune cells, known as dendritic cells (DCs). These cells have previously been shown to play an important role in the activation of the immune subsets that lead to ANAs. By using advanced research techniques, we will further characterize the functional differences between DCs from SARD patients and ANA+ individuals who have no symptoms. Additionally, we will elucidate the immune changes that distinguish the ANA+ individuals who progress, from those who do not. Ultimately, this study will define the immune mechanisms that result in the development of SARD and potentially lead to novel treatments that can be used to prevent disease.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nassar, Carol
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~